Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY. FMHR 2026, 4 (3), 4636-4645.